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Abstract  
Azoospermia affects approximately 15% of infertile males. Despite considerable 
research efforts in the last decades, in the majority of cases the cause remains 
unidentified. Chromosomal abnormalities and Yq microdeletions have been thoroughly 
studied, yet only account for 17% of azoospermic men. In fact, little is known about the 
contribution of the hemizygous X-linked and autosomal genes to male infertility.  This 
study focuses on the validation of rare deletions encompassing candidate genes on the X 
chromosome and on the autosomes, previously identified by Affymetrix 6.0 SNP Array, in a 
cohort of 166 Portuguese individuals with severe spermatogenic impairment (non-
obstructive azoospermia and severe oligozoospermia). As expected, the protein-coding 
genes CXORF48, and MAGEA8, as well as a miRNA (hsa-mir-4330) could not be amplified 
by PCR from the single X chromosome of the patients suspected of carrying deletions. 
These rearrangements will be further validated by aCGH (array Comparative Genomic 
Hybridization). Additionally, by MLPA analysis on 11p13 we confirmed a large deletion 
(~1Mb) spanning the WT1 gene - a conserved transcription factor known to play a crucial 
role in gonadal differentiation. A retrospective clinical evaluation of this patient revealed 
partial gonadal dysgenesis, consistent with a causal role for the newly discovered deletion. 
These results reveal new candidate genes for a role in spermatogenic pathways and 
suggest that haploinsufficiency of proteins important for the development of the male 
reproductive system can lead to spermatogenic dysfunction.  
 
 
